Skip to main content
Synbiotic SE logo

Synbiotic SE — Investor Relations & Filings

Ticker · SBX ISIN · DE000A3E5A59 LEI · 48510041U2G1IWA3R418 F Manufacturing
Filings indexed 140 across all filing types
Latest filing 2023-11-29 Earnings Release
Country DE Germany
Listing F SBX

About Synbiotic SE

https://www.synbiotic.com/

Synbiotic SE is a European corporate group focused on the medical cannabis and industrial hemp markets. The company operates a platform model, making strategic investments in ventures across these sectors to create synergies. Its business is vertically integrated, covering the entire value chain from cultivation, research, and development to the production, sales, and distribution of hemp- and cannabinoid-based products. The company's portfolio includes a wide range of high-quality hemp, CBD, and cannabis products, leveraging its expertise across the full supply chain from seed to shelf.

Recent filings

Filing Released Lang Actions
SynBiotic SE auf Wachstumskurs: Unternehmensgruppe verzeichnetSteigerung der Marktnachfrage und erwartet Umsatzverdopplung
Earnings Release Classification · 100% confidence The document is a news release dated November 29, 2023, from SynBiotic SE, announcing positive business developments, increased market demand, and an expectation of revenue doubling based on the planned legalization of cannabis in Germany. It contains forward-looking statements, management commentary, and details about the company's strategy (Buy & Build). Crucially, the footer explicitly states: "29.11.2023 CET/CEST Veröffentlichung einer Corporate News/Finanznachricht, übermittelt durch EQS News – ein Service der EQS Group AG." This structure—a news announcement about performance and outlook, distributed via a news service—is characteristic of an Earnings Release (ER) or a general corporate announcement. Since it focuses on financial outlook and performance highlights rather than being a full, comprehensive quarterly report (IR) or a transcript (CT), 'ER' is the most appropriate classification. It is not a short announcement merely pointing to an attached report, as the content itself is substantial (7424 chars) and contains the core financial narrative. * It is not 10-K (Annual Report) or IR (Interim Report) as it is a press release format. * It is not a CT (Call Transcript). * It is not an RPA (Report Publication Announcement) because it contains the substance of the news, not just an announcement that a report is coming. * It fits best as an Earnings Release (ER) as it discusses recent performance (Q4 2023) and provides future guidance (revenue doubling). Q4 2023
2023-11-29 German
SynBiotic SE: Daniel Kruse, buy
Director's Dealing Classification · 100% confidence The document explicitly contains the header "Directors’ Dealings" and details a transaction (Acquisition) by a person discharging managerial responsibilities (Daniel Kruse, Geschäftsführender Direktor). This directly matches the definition for Director's Dealing, which corresponds to the filing code DIRS.
2023-11-28 English
SynBiotic SE: Frank Otto, Wandlung einer Wandelschuldverschreibung in 98.465 Aktien der Gesellschaft
Director's Dealing Classification · 100% confidence The document is titled 'Directors’ Dealings' and explicitly states it is a 'Meldung und öffentliche Bekanntgabe der Geschäfte von Personen, die Führungsaufgaben wahrnehmen' (Notification and public disclosure of transactions by persons discharging managerial responsibilities). It details a transaction (conversion of a convertible bond into shares) by a member of the Supervisory Board ('Aufsichtsrat'), Frank Otto. This directly corresponds to the definition of Director's Dealing.
2023-10-23 German
Vorstandswechsel bei SynBiotic SE Lars Muller ubergibt Geschaftsfuhrung an Daniel Kruse
Board/Management Information Classification · 100% confidence The document is a press release announcing a change in senior management ('Vorstandswechsel'). Specifically, Lars Müller is stepping down as Managing Director and Daniel Kruse is taking over the sole management role, effective after the Annual General Meeting (Hauptversammlung). This directly corresponds to the definition of Board/Management Information (MANG), which covers announcements of changes in senior management.
2023-09-29 German
SynBiotic SE: Niederlegung des Geschaftsfuhrenden Direktors
Board/Management Information Classification · 100% confidence The document is an 'Ad-hoc Mitteilung' (Ad hoc announcement) dated September 29, 2023, explicitly stating the 'Niederlegung des Geschäftsführenden Direktors' (Resignation of the Managing Director). This content directly relates to a change in senior management personnel. According to the definitions, 'Board/Management Information (Code: MANG)' covers the 'Announcement of changes in the company's board of directors or senior management.' The document is short and serves as an immediate notification, fitting the profile of a specific personnel announcement rather than a comprehensive report.
2023-09-29 German
SynBiotic SE: Erfolgreicher Abschluss einer Kapitalerhohung (Vollplatzierung) sowie der Begebung einer Wandelschuldverschreibung
Capital/Financing Update Classification · 99% confidence The document is an 'Ad-hoc' announcement dated September 29, 2023, titled 'SynBiotic SE: Erfolgreicher Abschluss einer Kapitalerhöhung (Vollplatzierung) sowie der Begebung einer Wandelschuldverschreibung' (Successful completion of a capital increase (full placement) and the issuance of a convertible bond). The text explicitly details the placement of new shares and the issuance of convertible bonds, resulting in gross proceeds of approximately EUR 3.59 million. This content directly relates to fundraising, financing activities, and changes in capital structure. Therefore, the most appropriate classification is 'Capital/Financing Update' (CAP).
2023-09-29 German

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.